Glucagon-like peptide-1(7-36)amide and cytoplasmic calcium in insulin producing cells.
Ahrén
B
B
Department of Medicine, Lund University, Malmö, Sweden.
Simonsson
E
E
Karlsson
S
S
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D003593:Cytoplasm / Q000737:chemistry; D016257:Fura-2; D005934:Glucagon / Q000494:pharmacology; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D007328:Insulin / Q000096:biosynthesis*; D007340:Insulinoma; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011498:Protein Precursors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012844:Sincalide / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D007328:Insulin; D018377:Neurotransmitter Agents; D010446:Peptide Fragments; D010726:Phosphodiesterase Inhibitors; D011498:Protein Precursors; C055453:glucagon-like peptide 1 (7-36)amide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D012844:Sincalide; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine; D016257:Fura-2